[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].

© 2015, Silicea-Poligraf. All Rights Reserved. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

[1]  Giuseppe Limongelli,et al.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.

[2]  Johan Duflou,et al.  Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. , 2014, Heart rhythm.

[3]  P. Lambiase,et al.  Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.

[4]  Natesa G Pandian,et al.  Investigation of Global and Regional Myocardial Mechanics With 3-Dimensional Speckle Tracking Echocardiography and Relations to Hypertrophy and Fibrosis in Hypertrophic Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.

[5]  A. Gómez-Outes,et al.  Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups , 2013, Thrombosis.

[6]  R. D'Alessandro,et al.  Skeletal muscle involvement in cardiomyopathies , 2013, Journal of Cardiovascular Medicine.

[7]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[8]  A. Camm,et al.  Left ventricular outflow tract obstruction , 2013 .

[9]  L. Appel,et al.  Relationship of Left Ventricular Hypertrophy and Diastolic Function With Cardiovascular and Renal Outcomes in African Americans With Hypertensive Chronic Kidney Disease , 2013, Hypertension.

[10]  V. Kamperidis,et al.  Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[11]  Perry M Elliott,et al.  Genetic biomarkers in hypertrophic cardiomyopathy. , 2013, Biomarkers in medicine.

[12]  P. Elliott,et al.  Systematic review of atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy , 2013 .

[13]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[14]  S. Ommen,et al.  Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy. , 2013, The Annals of thoracic surgery.

[15]  D. Todd,et al.  United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  N. Smedira,et al.  Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction , 2013, Circulation.

[17]  M. Sherrid,et al.  Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With &bgr;-Blockade or Verapamil , 2013, Circulation. Heart failure.

[18]  M. Sherrid,et al.  Post-prandial upright exercise echocardiography in hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.

[19]  M. Yacoub,et al.  Erratum to: Early Results of Sarcomeric Gene Screening from the Egyptian National BA-HCM Program , 2013, Journal of Cardiovascular Translational Research.

[20]  Y. Pinto,et al.  Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[21]  Perry M Elliott,et al.  A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations , 2013, Heart.

[22]  David A Bluemke,et al.  Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. , 2013, Journal of cardiovascular computed tomography.

[23]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[24]  M. Link,et al.  Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.

[25]  J. Vogt,et al.  Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. , 2013, The Canadian journal of cardiology.

[26]  Eckart Fleck,et al.  Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. , 2013, European heart journal cardiovascular Imaging.

[27]  Stefan L. Zimmerman,et al.  Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic Cardiomyopathy , 2013, Circulation. Cardiovascular imaging.

[28]  A. Dawnay,et al.  Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. , 2013, European heart journal.

[29]  B. Schmidt,et al.  Epicardial ablation of monomorphic ventricular tachycardia storm in hypertrophic cardiomyopathy. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  H. Saal,et al.  Ethical and Policy Issues in Genetic Testing and Screening of Children , 2013, Pediatrics.

[31]  F. Salvi,et al.  Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. , 2013, European heart journal.

[32]  Claudia Giambartolomei,et al.  Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing , 2013, Journal of Medical Genetics.

[33]  T. Betts,et al.  Epicardial ablation of monomorphic ventricular tachycardia in a case of hypertrophic cardiomyopathy with apical aneurysm. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  Asterios Karagiannis,et al.  Efficacy of Various “Classic” Echocardiographic and Laboratory Indices in Distinguishing the “Gray Zone” between Athlete's Heart and Hypertrophic Cardiomyopathy: A Pilot Study , 2013, Echocardiography.

[35]  S. Ommen,et al.  Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. , 2013, The Annals of thoracic surgery.

[36]  M. Scanavacca,et al.  Evaluation of the autonomic function in patients with hypertrophic cardiomyopathy with and without syncope. , 2013, Arquivos brasileiros de cardiologia.

[37]  B. Gersh,et al.  Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope. , 2013, The American journal of cardiology.

[38]  K. Siminovitch,et al.  Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.

[39]  P. Knaapen,et al.  Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography. , 2013, European heart journal cardiovascular Imaging.

[40]  Mathew G. Wilson,et al.  Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population , 2013, British Journal of Sports Medicine.

[41]  P. Lambiase,et al.  A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy , 2013, Heart.

[42]  L. Køber,et al.  Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents: A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing , 2013, Circulation.

[43]  C. Vosa,et al.  Asymmetric septal hypertrophy in patients with severe aortic stenosis: the usefulness of associated septal myectomy. , 2013, The Journal of thoracic and cardiovascular surgery.

[44]  C. Wanner,et al.  Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease. , 2013, JIMD reports.

[45]  E. Bratt,et al.  Quality of life in asymptomatic children and adolescents before and after diagnosis of hypertrophic cardiomyopathy through family screening. , 2013, Journal of clinical nursing.

[46]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[47]  B. Gersh,et al.  Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2012, Circulation.

[48]  L. Jordaens,et al.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.

[49]  Jeroen J. Bax,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[50]  M. Andreassi,et al.  Next generation sequencing in cardiovascular diseases. , 2012, World journal of cardiology.

[51]  Matthew M Sumpter,et al.  Evidence for risk of cardiomyopathy with hydroxychloroquine , 2012, Lupus.

[52]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[53]  G. Aquaro,et al.  Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012 .

[54]  B. Maron,et al.  β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.

[55]  S. Colan,et al.  Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. , 2012, American heart journal.

[56]  L. Jordaens,et al.  Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy: Systematic Review and Meta-Analysis , 2012, Circulation. Heart failure.

[57]  D. Mancini,et al.  Cardiac transplantation in patients with hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.

[58]  J. Pepper,et al.  Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[59]  Eloisa Arbustini,et al.  Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. , 2012, Human molecular genetics.

[60]  M. Maron,et al.  Controversies in cardiovascular medicine Pharmacological treatment options for hypertrophic cardiomyopathy : high time for evidence , 2012 .

[61]  A. Branzi,et al.  Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. , 2012, JACC. Cardiovascular imaging.

[62]  M. Abel,et al.  Transapical Approach for Apical Myectomy and Relief of Midventricular Obstruction in Hypertrophic Cardiomyopathy , 2012, Journal of cardiac surgery.

[63]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[64]  M. Yacoub,et al.  Patterns of Disease Progression in Hypertrophic Cardiomyopathy: An Individualized Approach to Clinical Staging , 2012, Circulation. Heart failure.

[65]  P. Lambiase,et al.  Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[66]  K P George,et al.  Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum , 2012, British Journal of Sports Medicine.

[67]  S. Ommen,et al.  Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis. , 2012, JACC. Cardiovascular interventions.

[68]  M. Nieminen,et al.  Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy. , 2012, American journal of hypertension.

[69]  B. Firwana,et al.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy. , 2012, The Cochrane database of systematic reviews.

[70]  S. Ommen,et al.  Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.

[71]  P. Lambiase,et al.  The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[72]  A. Gavazzi,et al.  A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy , 2012, European heart journal.

[73]  C. Kramer,et al.  Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[74]  P. Elliott,et al.  Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy: Disease Expression in Relation to Age, Gender, and Long Term Outcome , 2012, Circulation. Cardiovascular genetics.

[75]  A. Wilde,et al.  Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers. , 2012, European heart journal cardiovascular Imaging.

[76]  B. Maron,et al.  Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy. , 2012, Progress in cardiovascular diseases.

[77]  P. Elliott,et al.  Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene , 2012, Circulation. Cardiovascular genetics.

[78]  H. Madeira,et al.  Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population. , 2012, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[79]  R. Fogari,et al.  Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[80]  W. Manning,et al.  Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy , 2011, Circulation. Cardiovascular imaging.

[81]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[82]  R. D'Alessandro,et al.  Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. , 2012, Future cardiology.

[83]  R. Bonow,et al.  Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging , 2012, The International Journal of Cardiovascular Imaging.

[84]  D. Atar,et al.  Dronedarone in high-risk permanent atrial fibrillation. , 2011, The New England journal of medicine.

[85]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[86]  G. Giannakoulas,et al.  Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy. , 2011, International journal of cardiology.

[87]  P. Scuffham,et al.  A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy , 2011, Heart.

[88]  A. Kobori,et al.  Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy , 2011, Cardiovascular ultrasound.

[89]  G. Ailawadi,et al.  Use of a Left Ventricular Assist Device in Hypertrophic Cardiomyopathy , 2011, Journal of cardiac surgery.

[90]  C. Semsarian,et al.  Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. , 2011, International journal of cardiology.

[91]  P. Elliott,et al.  Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey , 2011, Heart.

[92]  I. Ranasinghe,et al.  Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy. , 2011, Heart, lung & circulation.

[93]  T. Kubo,et al.  Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[94]  L. Mestroni,et al.  High-throughput Genotyping Robot-assisted Method for Mutation Detection in Patients With Hypertrophic Cardiomyopathy , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[95]  G. Marcus,et al.  Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. , 2011, Journal of the American College of Cardiology.

[96]  M. Henein,et al.  Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy. , 2011, International journal of cardiology.

[97]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[98]  P. Lambiase,et al.  The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy , 2011, Heart.

[99]  P. Kirchhof,et al.  Management of patients with palpitations: a position paper from the European Heart Rhythm Association. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[100]  R. Kim,et al.  LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. , 2011, JACC. Cardiovascular imaging.

[101]  B. Yashiro,et al.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[102]  F. Salvi,et al.  Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. , 2011, JACC. Cardiovascular imaging.

[103]  P. Pieper,et al.  Systematic review of pregnancy in women with inherited cardiomyopathies , 2011, European journal of heart failure.

[104]  K. Dou,et al.  Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review. , 2011, Chinese medical journal.

[105]  T. S. Chee,et al.  Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[106]  G. Kervio,et al.  The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. , 2011, European heart journal.

[107]  M. Gold,et al.  Defibrillation Thresholds in Hypertrophic Cardiomyopathy , 2011, Journal of cardiovascular electrophysiology.

[108]  S. Kushwaha,et al.  Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic Cardiomyopathy , 2011, Circulation. Heart failure.

[109]  R. Hauer,et al.  Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. , 2011, European heart journal.

[110]  Hugo A. Katus,et al.  Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomyopathies , 2011, Circulation. Cardiovascular genetics.

[111]  W. Stevenson,et al.  Long-Term Outcomes of Combined Epicardial and Endocardial Ablation of Monomorphic Ventricular Tachycardia Related to Hypertrophic Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.

[112]  B. Maron,et al.  Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. , 2011, The American journal of cardiology.

[113]  S. Perlman,et al.  Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). , 2011, American heart journal.

[114]  P. Lambiase,et al.  Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[115]  D. MacIver.  A new method for quantification of left ventricular systolic function using a corrected ejection fraction. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[116]  A. Oto,et al.  Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy. , 2011, Journal of interventional cardiology.

[117]  J. Brugada,et al.  Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study. , 2011, Heart rhythm.

[118]  M. Schloesser,et al.  Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. , 2011, Journal of the American College of Cardiology.

[119]  Johanna Kuusisto,et al.  Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation , 2011, European Radiology.

[120]  P. Pernet,et al.  Electrical cardioversion during pregnancy: safe or not? , 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[121]  Joseph D. Kay,et al.  Heart Rate Response During Exercise and Pregnancy Outcome in Women With Congenital Heart Disease , 2011, Circulation.

[122]  M. Muiesan,et al.  Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice , 2011, Blood pressure.

[123]  S. Antonarakis,et al.  Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice , 2011, Journal of Medical Genetics.

[124]  W. Stevenson,et al.  Substrate Characterization and Catheter Ablation for Monomorphic Ventricular Tachycardia in Patients With Apical Hypertrophic Cardiomyopathy , 2011, Journal of cardiovascular electrophysiology.

[125]  W. Manning,et al.  Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy , 2010, Circulation.

[126]  童鸿.  Recommendations for Interpretation of 12-lead Electrocardiogram in the Athlete , 2011 .

[127]  M. Sherrid,et al.  Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[128]  H. Watkins,et al.  Inherited cardiomyopathies. , 2011, The New England journal of medicine.

[129]  T. Ohtsuki,et al.  Two cases of cerebral embolism caused by apical thrombi in midventricular obstructive cardiomyopathy. , 2011, Internal medicine.

[130]  F. Salvi,et al.  Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[131]  Giuseppe Boriani,et al.  Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[132]  A. Rynkiewicz,et al.  Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. , 2010, European heart journal.

[133]  L. Monserrat,et al.  Insights into genotype–phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3 , 2010, Heart.

[134]  S. Qiao,et al.  Follow-up by cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy who underwent percutaneous ventricular septal ablation. , 2010, The American journal of cardiology.

[135]  A. Keren,et al.  Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[136]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[137]  B. Maron,et al.  Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[138]  T. Dickfeld,et al.  Defibrillation Threshold Testing in Patients with Hypertrophic Cardiomyopathy , 2010, Pacing and clinical electrophysiology : PACE.

[139]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[140]  Eckart Fleck,et al.  Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[141]  Udo Sechtem,et al.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[142]  B. Mulder,et al.  Predictors of pregnancy complications in women with congenital heart disease. , 2010, European heart journal.

[143]  M. Maron,et al.  Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[144]  I. Kowalik,et al.  Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.

[145]  Agnes Pasquet,et al.  Recommendations for transoesophageal echocardiography: update 2010. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[146]  W. Toff,et al.  Fitness to fly for passengers with cardiovascular disease. , 2010, Heart.

[147]  W. Rużyłło,et al.  Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy. , 2010, Kardiologia polska.

[148]  S. Tezenas du Montcel,et al.  Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging. , 2010, European heart journal.

[149]  A. Angelini,et al.  Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy , 2010, European heart journal.

[150]  P. Serruys,et al.  Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy: A Word of Caution , 2010, Circulation. Heart failure.

[151]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[152]  Michael J Ackerman,et al.  Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. , 2010, Journal of the American College of Cardiology.

[153]  H. Watkins,et al.  DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. , 2010, European heart journal.

[154]  D. Mele,et al.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment , 2010, Cardiovascular ultrasound.

[155]  D. Simel,et al.  Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy: Comparative Rates of Overall Mortality and Sudden Cardiac Death After Treatment , 2010, Circulation. Cardiovascular interventions.

[156]  Michel Haissaguerre,et al.  Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[157]  N. Smedira,et al.  Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[158]  Matthew W. Martinez,et al.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.

[159]  M. Sheppard,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[160]  N. Tuseth,et al.  Asymmetric septal hypertrophy – a marker of hypertension in aortic stenosis (a SEAS substudy) , 2010, Blood pressure.

[161]  A. Tajik,et al.  Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[162]  J. Towbin,et al.  Diagnostic, Prognostic and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy , 2010 .

[163]  Satoshi Okayama,et al.  Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. , 2010, Journal of cardiovascular computed tomography.

[164]  L. Monserrat,et al.  Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy. , 2010, Revista espanola de cardiologia.

[165]  Nora Toma,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, Maedica.

[166]  G. Boriani,et al.  Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[167]  P. Lambiase,et al.  Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. , 2009, European heart journal.

[168]  C. C. Castro,et al.  Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups). , 2009, Arquivos brasileiros de cardiologia.

[169]  A. Wilde,et al.  Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy. , 2009, Heart rhythm.

[170]  M. Sherrid,et al.  Severe Symptoms in Mid and Apical Hypertrophic Cardiomyopathy , 2009, Echocardiography.

[171]  G. Giannakoulas,et al.  Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[172]  J. Staessen,et al.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial , 2009, The Lancet.

[173]  E. Arbustini,et al.  Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy , 2009, Pediatric transplantation.

[174]  J. Le Heuzey,et al.  Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[175]  B. Gersh,et al.  Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. , 2009, Journal of the American College of Cardiology.

[176]  O. Wever-Pinzon,et al.  Reflections of inflections in hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[177]  N. Smedira,et al.  Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.

[178]  A. Tajik,et al.  Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. , 2009, Journal of the American College of Cardiology.

[179]  J. Towbin,et al.  Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. , 2009, Journal of the American College of Cardiology.

[180]  S. Siu,et al.  Choosing the best contraceptive method for the adult with congenital heart disease , 2009, Current cardiology reports.

[181]  D. Corrado,et al.  Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. , 2009, European heart journal.

[182]  W. Shimizu,et al.  QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[183]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[184]  Ana Morales,et al.  Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2009, Circulation. Heart failure.

[185]  D. Sorysz,et al.  Left Ventricular Outflow Tract Gradient Provoked by Upright Position or Exercise in Treated Patients with Hypertrophic Cardiomyopathy without Obstruction at Rest , 2009, Echocardiography.

[186]  E. Aliot,et al.  Indications for the use of diagnostic implantable and external ECG loop recorders. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[187]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[188]  C. Autore,et al.  Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy , 2009, Circulation.

[189]  B. Maron,et al.  Successful Catheter Ablation of Hemodynamically Unstable Monomorphic Ventricular Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Apical Aneurysm , 2009, Journal of cardiovascular electrophysiology.

[190]  B. Gersh,et al.  Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy , 2009, Heart.

[191]  L. Hougs,et al.  Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives , 2009, Human mutation.

[192]  M. P. van den Berg,et al.  Family letters are an effective way to inform relatives about inherited cardiac disease , 2009, American journal of medical genetics. Part A.

[193]  S. Solomon,et al.  Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy , 2009, Circulation.

[194]  Arturo Evangelista,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[195]  J. Schulz-Menger,et al.  Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. , 2009, Journal of the American College of Cardiology.

[196]  Harald Becher,et al.  Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[197]  B. Maron,et al.  Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy , 2009 .

[198]  J. Stockman.  Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2009 .

[199]  J. Stockman.  Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2009 .

[200]  A. Waldo.  Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2009 .

[201]  M. Chiariello,et al.  Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[202]  Jeroen J. Bax,et al.  Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. , 2008, JACC. Cardiovascular imaging.

[203]  B. Gersh,et al.  Circadian Rhythm of Appropriate Implantable Cardioverter Defibrillator Discharges in Patients with Hypertrophic Cardiomyopathy , 2008, Pacing and clinical electrophysiology : PACE.

[204]  S. Nagueh,et al.  Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. , 2008, JACC. Cardiovascular interventions.

[205]  S. Miura,et al.  Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy. , 2008, International journal of cardiology.

[206]  Warren J Manning,et al.  Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.

[207]  Luigi Rega,et al.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[208]  B. Gersh,et al.  Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2008, Circulation.

[209]  B. Maron,et al.  Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. , 2008, The American journal of cardiology.

[210]  D. Hagler,et al.  Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[211]  Rachael,et al.  Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.

[212]  M. Digilio,et al.  Leopard syndrome , 2008, Orphanet journal of rare diseases.

[213]  P. Cordeiro,et al.  Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy , 2008, Cardiovascular ultrasound.

[214]  Eugene H Blackstone,et al.  Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. , 2008, The Annals of thoracic surgery.

[215]  P. Lambiase,et al.  Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end‐stage hypertrophic cardiomyopathy , 2008, European journal of heart failure.

[216]  R. Arena,et al.  Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy. , 2008, Medicine and science in sports and exercise.

[217]  Heidi L Rehm,et al.  Shared genetic causes of cardiac hypertrophy in children and adults. , 2008, The New England journal of medicine.

[218]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[219]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[220]  W. Manning,et al.  Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.

[221]  Jeroen J. Bax,et al.  Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. , 2008, European heart journal.

[222]  G. Boriani,et al.  Heart transplantation in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.

[223]  L. Trinquart,et al.  Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. , 2008, European heart journal.

[224]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[225]  W. Mckenna,et al.  Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation , 2007, Heart.

[226]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2008 .

[227]  B. Fivush,et al.  Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. , 2008, The Journal of pediatrics.

[228]  P. Pellikka,et al.  Dynamic left ventricular outflow tract obstruction evoked by exercise echocardiography: prevalence and predictive factors in a prospective study. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[229]  N. Smedira,et al.  Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. , 2008, The Annals of thoracic surgery.

[230]  M. Sheppard,et al.  Guidelines for autopsy investigation of sudden cardiac death , 2007, Virchows Archiv.

[231]  C. Stellbrink,et al.  Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience , 2008, Clinical Research in Cardiology.

[232]  S. Ommen,et al.  Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization , 2007, Circulation.

[233]  A. Keren,et al.  Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy , 2007, Heart.

[234]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[235]  S. Kunimoto,et al.  Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy Associated with an Apical Aneurysm: Evaluation of Possible Causes of Aneurysm Formation , 2007, Yonsei medical journal.

[236]  D. Fassbender,et al.  One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response , 2007, Clinical Research in Cardiology.

[237]  F. Walker,et al.  Hyperthrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. , 2007, Minerva anestesiologica.

[238]  M. Frenneaux,et al.  Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[239]  B. Gersh,et al.  Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience , 2007, Nature Clinical Practice Cardiovascular Medicine.

[240]  Lucas M Bachmann,et al.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review , 2007, BMJ : British Medical Journal.

[241]  G. Di Salvo,et al.  Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. , 2007, The American journal of cardiology.

[242]  Mario J. Garcia,et al.  Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.

[243]  D. Fassbender,et al.  Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances. , 2007, International journal of cardiology.

[244]  P. Elliott,et al.  Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. , 2007, Journal of the American College of Cardiology.

[245]  F. Gaita,et al.  Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2007, The American journal of cardiology.

[246]  P. Shiels,et al.  Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy. , 2007, The Journal of invasive cardiology.

[247]  K. Hayashi,et al.  Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis. , 2007, Clinical science.

[248]  M. ROTH-KLEINER,et al.  Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. , 2007, European heart journal.

[249]  B. Maron,et al.  Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy , 2007, Heart.

[250]  G. Boriani,et al.  Electrophysiologic Manifestations of Ventricular Tachyarrhythmias Provoking Appropriate Defibrillator Interventions in High‐Risk Patients with Hypertrophic Cardiomyopathy , 2007, Journal of cardiovascular electrophysiology.

[251]  S. Prasad,et al.  Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy , 2007, Current cardiology reports.

[252]  Zhi-hong Han,et al.  [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy]. , 2007, Zhonghua xin xue guan bing za zhi.

[253]  J. Krieger,et al.  Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. , 2007, Arquivos brasileiros de cardiologia.

[254]  A. Tajik,et al.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[255]  Y. Pinto,et al.  Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. , 2006, Journal of the American College of Cardiology.

[256]  Eloisa Arbustini,et al.  Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[257]  J. Cassiman,et al.  Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers , 2006, Clinical genetics.

[258]  Barry J Maron,et al.  The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. , 2006, Circulation.

[259]  M. Janabi,et al.  Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania , 2006, Tropical doctor.

[260]  B. Maron,et al.  Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). , 2006, The American journal of cardiology.

[261]  J. Pu,et al.  Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis. , 2006, International journal of cardiology.

[262]  J. Zwanenburg,et al.  Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: A PET and MRI study , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[263]  Stuart Russell,et al.  Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[264]  P. Elliott,et al.  Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy , 2006, Heart.

[265]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[266]  W. Manning,et al.  Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[267]  G. Keren,et al.  Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. , 2006, The American journal of cardiology.

[268]  P. Calabrò,et al.  Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[269]  L. Monserrat,et al.  Magnetic Resonance Imaging of Delayed Enhancement in Hypertrophic Cardiomyopathy: Relationship with Left Ventricular Perfusion and Contractile Function , 2006, Journal of computer assisted tomography.

[270]  J. Narula,et al.  Review of noninvasive imaging for hypertrophic cardiac syndromes and restrictive physiology. , 2006, Heart failure clinics.

[271]  Michael J Ackerman,et al.  Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. , 2006, Mayo Clinic proceedings.

[272]  M. Laakso,et al.  Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. , 2006, American heart journal.

[273]  S. Themistoclakis,et al.  Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. , 2006, Heart rhythm.

[274]  W. Mckenna,et al.  Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy , 2005, Heart.

[275]  W. Frishman.  Gender-related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy , 2006 .

[276]  D. Holmgren,et al.  Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly , 2005, Cardiology in the Young.

[277]  Seok‐Min Kang,et al.  Tissue Doppler-derived indices predict exercise capacity in patients with apical hypertrophic cardiomyopathy. , 2005, Chest.

[278]  J. Seidman,et al.  Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling , 2005, Journal of Medical Genetics.

[279]  R. Falk.  Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.

[280]  J. Carlin,et al.  Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.

[281]  J. Cassiman.  Research network: EuroGentest – a European Network of Excellence aimed at harmonizing genetic testing services , 2005, European Journal of Human Genetics.

[282]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[283]  A. Tajik,et al.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[284]  B. Maron,et al.  Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. , 2005, Heart rhythm.

[285]  B. Maron,et al.  Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. , 2005, The American journal of cardiology.

[286]  W. Mckenna,et al.  Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy , 2005, Heart.

[287]  A. Tajik,et al.  Yield of genetic testing in hypertrophic cardiomyopathy. , 2005, Mayo Clinic proceedings.

[288]  W. Williams,et al.  Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy , 2005, Circulation.

[289]  B. Maron,et al.  Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[290]  C. Autore,et al.  The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. , 2005, Journal of the American College of Cardiology.

[291]  P. Elliott,et al.  Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. , 2005, Journal of the American College of Cardiology.

[292]  B. Maron,et al.  Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[293]  P. Verdecchia,et al.  Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value , 2005, Hypertension.

[294]  E. Benedetti,et al.  Reversal of tacrolimus‐related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6‐year‐old recipient , 2005, Pediatric transplantation.

[295]  Stefan Neubauer,et al.  Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[296]  T. Kato,et al.  Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography , 2004, Circulation.

[297]  J. Schulz-Menger,et al.  Percutaneous Transluminal Septal Artery Ablation Using Polyvinyl Alcohol Foam Particles for Septal Hypertrophy in Patients with Hypertrophic Obstructive Cardiomyopathy: Acute and 3-Year Outcomes , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[298]  M. Nieminen,et al.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. , 2004, JAMA.

[299]  D. Fassbender,et al.  Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. , 2004, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[300]  I. Ţintoiu,et al.  Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. , 2004, Kardiologia polska.

[301]  H. Matsubara,et al.  Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[302]  M. Komajda,et al.  Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case , 2004, Prenatal diagnosis.

[303]  L. Armadans,et al.  Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[304]  S. Mickelsen,et al.  Doppler Evaluation of the Descending Aorta in Patients with Hypertrophic Cardiomyopathy: Potential for Assessing the Functional Significance of Outflow Tract Gradients and for Optimizing Pacemaker Function , 2004, Journal of interventional cardiac electrophysiology.

[305]  M. Komajda,et al.  Calcified mediastinal haematoma: a rare case of cardiac constriction , 2004, Heart.

[306]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[307]  B. Maron,et al.  Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). , 2004, American Journal of Cardiology.

[308]  D. Pennell,et al.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.

[309]  I. Ferrer,et al.  Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies , 2004, Journal of the Neurological Sciences.

[310]  M. Carrier,et al.  Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[311]  B. Maron,et al.  Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. , 2004, Journal of Thoracic and Cardiovascular Surgery.

[312]  N. Smedira,et al.  Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[313]  P. Stassano,et al.  Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up. , 2004, Texas Heart Institute journal.

[314]  R. Hui,et al.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.

[315]  F. Girolami,et al.  Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany. , 2003, The American journal of cardiology.

[316]  B. Godard,et al.  Population genetic screening programmes: principles, techniques, practices, and policies , 2003, European Journal of Human Genetics.

[317]  D. Pennell,et al.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.

[318]  A. Tajik,et al.  Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease , 2003, Circulation.

[319]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[320]  A. Tajik,et al.  Myocardial bridging in adult patients with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[321]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[322]  Erik G. Ellsworth,et al.  Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy , 2003, Circulation.

[323]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[324]  M. Komajda,et al.  Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. , 2003, International journal of cardiology.

[325]  M. S. Hamid,et al.  Pregnancy related complications in women with hypertrophic cardiomyopathy , 2003, Heart.

[326]  B. Maron,et al.  Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. , 2003, The American journal of cardiology.

[327]  Douglas S Lee,et al.  Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[328]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[329]  E John Orav,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[330]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in a young male military population. , 2003, The American journal of cardiology.

[331]  F. T. ten Cate,et al.  Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.

[332]  O. Havndrup,et al.  Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. , 2003, Cardiovascular research.

[333]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[334]  Provision of genetic services in Europe: current practices and issues , 2003, European Journal of Human Genetics.

[335]  Genetic information and testing in insurance and employment: technical, social and ethical issues , 2003, European Journal of Human Genetics.

[336]  E. D. Wigle,et al.  Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy , 2003 .

[337]  C. Autore,et al.  Risk associated with pregnancy in hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[338]  H. Dige-Petersen,et al.  Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. , 2002, American heart journal.

[339]  E. Zackai,et al.  Further delineation of cardiac abnormalities in Costello syndrome. , 2002, American journal of medical genetics.

[340]  N. Cardim,et al.  Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy. , 2002, The American journal of cardiology.

[341]  D. Rao,et al.  Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study. , 2002, American heart journal.

[342]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[343]  B. Maron,et al.  Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning , 2002, Circulation.

[344]  J. Staessen,et al.  Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients: Results of the Baragwanath Trial , 2002, Circulation.

[345]  B. Maron,et al.  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[346]  Wigle Ed,et al.  The diagnosis of hypertrophic cardiomyopathy , 2001, Heart.

[347]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[348]  S. Kato,et al.  Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. , 2001, Japanese circulation journal.

[349]  S. Siu,et al.  Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart Disease , 2001, Circulation.

[350]  M. Quiñones,et al.  Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy , 2001, Circulation.

[351]  A. Fraser,et al.  Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. , 2001, The American journal of cardiology.

[352]  R. Elles,et al.  Integrated regional genetic services: current and future provision. , 2001, BMJ : British Medical Journal.

[353]  M. Hennersdorf,et al.  Arterial hypertension and cardiac arrhythmias , 2001, Journal of hypertension.

[354]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[355]  W. Williams,et al.  Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. , 2000, Journal of the American College of Cardiology.

[356]  L. Fananapazir,et al.  Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. , 2000, Journal of the American College of Cardiology.

[357]  W. Mckenna,et al.  Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. , 2000, Journal of the American College of Cardiology.

[358]  W. Mckenna,et al.  Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. , 2000, The American journal of cardiology.

[359]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[360]  C. Wippermann,et al.  Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.

[361]  M. Decristofaro,et al.  Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function. , 2000, The Canadian journal of cardiology.

[362]  J. Stauffer,et al.  Subaortic obstruction after sildenafil in a patient with hypertrophic cardiomyopathy. , 1999, The New England journal of medicine.

[363]  K. Borisov,et al.  Management of Symptomatic Hypertrophic Obstructive Cardiomyopathy - Long-Term Results after Surgical Therapy , 1999, The Thoracic and cardiovascular surgeon.

[364]  M. Josephson,et al.  Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). , 1999, Circulation.

[365]  B. Maron,et al.  Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .

[366]  B. Maron,et al.  Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. , 1999, Journal of the American College of Cardiology.

[367]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[368]  C. Autore,et al.  Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. , 1999, Circulation.

[369]  S. Ward,et al.  Diagnostic utility of metabolic exercise testing in a patient with cardiovascular disease , 1999, Heart.

[370]  小橋 文香.  Solitary papillary muscle hypertrophy as a possible form of hypertrophic cardiomyopathy , 1999 .

[371]  I. Olivotto,et al.  Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy. , 1999, Giornale italiano di cardiologia.

[372]  B. Andersson,et al.  High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. , 1999, European heart journal.

[373]  B. Maron,et al.  Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. , 1998, Circulation.

[374]  U. Gleichmann,et al.  Outflow Acceleration Assessed by Continuous-Wave Doppler Echocardiography in Left Ventricular Hypertrophy: An Analysis of 103 Consecutive Cases , 1998, Cardiology.

[375]  U. Gleichmann,et al.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. , 1998, Circulation.

[376]  T. Imaizumi,et al.  Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[377]  M. Komajda,et al.  Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. , 1998, European heart journal.

[378]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[379]  A. Kisanuki,et al.  Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. , 1998, Circulation.

[380]  M. Verani,et al.  Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[381]  O. Hess,et al.  Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. , 1998, The Annals of thoracic surgery.

[382]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[383]  B. Maron,et al.  Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.

[384]  C. M. Lowe,et al.  Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. , 1998, European heart journal.

[385]  B. Grubb,et al.  Implantable cardioverter-defibrillators in children: a single-institutional experience. , 1998, The Annals of thoracic surgery.

[386]  M. Komajda,et al.  Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. , 1998, European heart journal.

[387]  P. Hanrath,et al.  Hypertrophic obstructive cardiomyopathy. , 1998, Advances in cardiac surgery.

[388]  W. Mckenna,et al.  Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[389]  R. Michler,et al.  Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. , 1997, The Journal of thoracic and cardiovascular surgery.

[390]  W. Mckenna,et al.  Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. , 1997, European heart journal.

[391]  M. Komajda,et al.  Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. , 1997, Circulation.

[392]  H. Watkins,et al.  Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.

[393]  J. Schläpfer,et al.  Dual Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy: Beneficial Effect of Atrioventricular Junction Ablation for Optimal Left Ventricular Capture and Filling , 1997, Pacing and clinical electrophysiology : PACE.

[394]  Y. Fujio,et al.  Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.

[395]  A. Tajik,et al.  Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. , 1997, Journal of the American College of Cardiology.

[396]  W. Mckenna,et al.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. , 1997, Heart.

[397]  I. Kronzon,et al.  The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy. , 1996, The New England journal of medicine.

[398]  G Campanella,et al.  The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. , 1996, American journal of human genetics.

[399]  A. Tajik,et al.  Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. , 1996, Circulation.

[400]  B. Maron,et al.  Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. , 1996, JAMA.

[401]  W. Mckenna,et al.  Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. , 1996, European heart journal.

[402]  David,et al.  Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. , 1996, Journal of the American College of Cardiology.

[403]  R. Schmieder,et al.  Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies , 1996 .

[404]  J. Skoularigis,et al.  Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy. , 1996, Chest.

[405]  P. Nihoyannopoulos,et al.  Symptoms of hypertrophic cardiomyopathy, with special emphasis on syncope and postprandial exacerbation of symptoms , 1996, Clinical cardiology.

[406]  R. Robbins,et al.  Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. , 1996, The Journal of thoracic and cardiovascular surgery.

[407]  P. Poole‐Wilson,et al.  Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. , 1996, Heart.

[408]  A. Camm,et al.  DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. , 1996, Heart.

[409]  N. Obuchowski,et al.  Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. , 1996, American journal of cardiac imaging.

[410]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[411]  B. Maron,et al.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.

[412]  F. Flachskampf,et al.  Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. , 1995, Circulation.

[413]  W. Williams,et al.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[414]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[415]  U. Sigwart.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.

[416]  David P Miller,et al.  Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results , 1995 .

[417]  S. Ito,et al.  Transesophageal echocardiographic evaluation of mitral regurgitation in hypertrophic cardiomyopathy: contributions of eccentric left ventricular hypertrophy and related abnormalities of the mitral complex. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[418]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[419]  G. Koren,et al.  Pregnancy outcome after gestational exposure to amiodarone in Canada. , 1995, American journal of obstetrics and gynecology.

[420]  James D. Thomas,et al.  763-5 Provocation of Latent Left Ventricular Outflow Tract Gradients with Amyl Nitrite and Exercise in Patients with Hypertrophic Cardiomyopathy , 1995 .

[421]  C. Autore,et al.  Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.

[422]  M. Proschan,et al.  Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. , 1994, The American journal of cardiology.

[423]  K. Berg,et al.  The effects of anabolic steroids on myocardial structure and cardiovascular fitness. , 1993, Medicine and science in sports and exercise.

[424]  J. Cox,et al.  Treatment of cardiac arrhythmias during pregnancy. , 1993, Progress in cardiovascular diseases.

[425]  M. Panja,et al.  Aortic regurgitation in hypertrophic cardiomyopathy. , 1993, The Journal of the Association of Physicians of India.

[426]  M A Proschan,et al.  Echocardiographic Assessment of Mitral Valve Size in Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen , 1993, Circulation.

[427]  B. Maron,et al.  Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. , 1993, British heart journal.

[428]  J. Wodniecki,et al.  Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. , 1993, Cardiology.

[429]  B. Maron,et al.  Initial Results of Combined Anterior Mitral Leaflet Plication and Ventricular Septal Myotomy‐Myectomy for Relief of Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy , 1992, Circulation.

[430]  E. Rosenkranz,et al.  Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.

[431]  W. Williams,et al.  Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. , 1992, Journal of the American College of Cardiology.

[432]  R. Cannon,et al.  Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.

[433]  P. Nihoyannopoulos,et al.  Investigation of a Hemodynamic Basis for Syncope in Hypertrophic Cardiomyopathy: Use of a Head‐Up Tilt Test , 1992, Circulation.

[434]  W. Roberts,et al.  Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.

[435]  W. Roberts,et al.  Anomalous Insertion of Papillary Muscle Directly Into Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy: Significance in Producing Left Ventricular Outflow Obstruction , 1991, Circulation.

[436]  D. Webb,et al.  Abnormal Vascular Responses to Supine Exercise in Hypertrophic Cardiomyopathy , 1991, Circulation.

[437]  R. E. Clark,et al.  Aortic regurgitation after left ventricular myotomy and myectomy. , 1991, The Annals of thoracic surgery.

[438]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[439]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[440]  M. Frenneaux,et al.  Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. , 1990, Circulation.

[441]  B. Marino,et al.  Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature. , 1990, European heart journal.

[442]  M. Frenneaux,et al.  Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[443]  W. Roberts,et al.  Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. , 1990, British heart journal.

[444]  M. Cheitlin,et al.  Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. , 1990, The American journal of cardiology.

[445]  A. Keren,et al.  The effect of disopyramide on uterine contractions during pregnancy. , 1990, American journal of obstetrics and gynecology.

[446]  R O Bonow,et al.  Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. , 1989, Circulation.

[447]  Z. Krajcer,et al.  Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. , 1989, Circulation.

[448]  T. Shiota,et al.  Aortic regurgitation associated with hypertrophic cardiomyopathy: a colour Doppler echocardiographic study. , 1989, British heart journal.

[449]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[450]  W. Williams,et al.  Aortic Regurgitation: A Common Complication After Surgery for Hypertrophic Obstructive Cardiomyopathy , 1989, Journal of the American College of Cardiology.

[451]  B. Maron,et al.  Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.

[452]  R. Bonow,et al.  Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. , 1989, Circulation.

[453]  W. Mckenna,et al.  Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm. , 1989, British heart journal.

[454]  K. Peterson,et al.  Hypertrophic cardiomyopathy and sudden death. , 1988, The New England journal of medicine.

[455]  N. Kaplan.  Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1988, The New England journal of medicine.

[456]  J. Hradec,et al.  The nature of cardiac hypertrophy in acromegaly: an echocardiographic study. , 1988, Cor et vasa.

[457]  H. Rakowski,et al.  Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. , 1988, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[458]  R. Bonow,et al.  Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.

[459]  M. Kaltenbach,et al.  Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy. , 1987, Zeitschrift fur Kardiologie.

[460]  T. Sakamoto,et al.  Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. , 1987 .

[461]  M. Webb-Peploe,et al.  Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy. , 1986, British heart journal.

[462]  W. Mckenna,et al.  Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment. , 1986, The American journal of cardiology.

[463]  Y. Koga,et al.  Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study. , 1986, Japanese heart journal.

[464]  B. Maron,et al.  Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. , 1986, Journal of the American College of Cardiology.

[465]  A. Castellanos,et al.  Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[466]  R. Bonow,et al.  Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy. , 1985, Circulation.

[467]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[468]  J. Dussaule,et al.  Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study. , 1985, American heart journal.

[469]  C. Oakley,et al.  Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.

[470]  R. Bonow,et al.  Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.

[471]  R. Bonow,et al.  The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy. , 1983, European heart journal.

[472]  W. McKenna,et al.  Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. , 1983, Journal of the American College of Cardiology.

[473]  A. Rocchini,et al.  Hemodynamic Effects of Verapamil in Children and Adolescents with Hypertrophic Cardiomyopathy , 1983, Circulation.

[474]  J. Goodwin,et al.  Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs. , 1982, British heart journal.

[475]  R. Bonow,et al.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. , 1981, The American journal of cardiology.

[476]  S. Epstein,et al.  Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. , 1981, Circulation.

[477]  J. Gottdiener,et al.  Hypertrophic Cardiomyopathy with Unusual Locations of Left Ventricular Hypertrophy Undetectable, by M‐mode Echocardiography: Identification by Wide‐angle Two‐dimensional Echocardiography , 1981, Circulation.

[478]  M. Davies,et al.  Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. , 1980, British heart journal.

[479]  B. Maron,et al.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. , 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

[480]  B. Maron,et al.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1979, Circulation.

[481]  W. Henry,et al.  Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1978, Circulation.

[482]  R. Leachman,et al.  Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients. , 1976, The Journal of cardiovascular surgery.

[483]  W. Henry,et al.  Operative Treatment in Hypertrophic Subaortic Stenosis: Techniques, and the Results of Pre and Postoperative Assessments in 83 Patients , 1975, Circulation.

[484]  M. Dunn,et al.  Anterior‐Superior Displacement of Papillary Muscles Producing Obstruction and Mitral Regurgitation in Idiopathic Hypertrophic Subaortic Stenosis: Operative Relief by Posterior‐Superior Realignment of Papillary Muscles Following Ventricular Septal Myectomy , 1974, Circulation.

[485]  E. W. Hancock,et al.  Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy. , 1973, The American journal of cardiology.

[486]  R. Balcon,et al.  Syncope in hypertrophic obstructive cardiomyopathy due to asystole. , 1972, British heart journal.

[487]  R. Gramiak,et al.  Long-term propranolol therapy in muscular subaortic stenosis. , 1970, British heart journal.

[488]  E. W. Hancock,et al.  Muscular Subaortic Stenosis: Prevention of Outflow Obstruction with Propranolol , 1968, Circulation.

[489]  C. Lambrew,et al.  Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.

[490]  E. Braunwald,et al.  Studies on Digitalis: V. Comparison of the Effects of Ouabain on Left Ventricular Dynamics in Valvular Aortic Stenosis and Hypertrophic Subaortic Stenosis , 1962, Circulation.